$CELG Recent News Celgene drops 1.9%, among wo
Post# of 94278
Posted On: 06/05/2014 10:39:11 AM
$CELG Recent News
Celgene drops 1.9%, among worst S&P 500 losers 9:32 a.m. May 29, 2014 - Sue Chang
Higher rates are coming — here’s how you prepare 8:38 a.m. May 12, 2014 - Jeff Reeves
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
What ‘Game of Thrones’ can teach you about money 8:30 a.m. April 5, 2014 - Wallace Witkowski
Biotechs, bonds and more from the 'tempest in a microsecond' 8:32 a.m. April 2, 2014 - Shawn Langlois
Play-it-safe stock investors may take some risk on jobs 8:31 a.m. March 30, 2014 - Wallace Witkowski
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - Russ Britt
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - Russ Britt
The Nasdaq has a message to deliver 1:57 p.m. March 20, 2014 - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:16 p.m. March 14, 2014 - Sue Chang
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
Winning approval for new drugs may get harder, analyst warns 4:56 p.m. Feb. 28, 2014 - Russ Britt
The market puts a few feathers in its cap 2:58 p.m. Jan. 23, 2014 - The Trading Deck
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Celgene's 2014 guidance falls below analyst views 1:19 p.m. Jan. 13, 2014 - MarketWatch.com
Jim Cramer's Top Stock Picks: PVH CELG REGN SKX 6:00 a.m. Today - TheStreet.com
Cramer's Mad Money - Skechers Is Totally Nailing It (6/4/14) 4:41 a.m. Today - Seeking Alpha
Celgene's (CELG) Management Hosts Jefferies Global Healthcare Conference (Transcript) 1:27 p.m. June 4, 2014 - Seeking Alpha
A Celgene Satellite: An Interview With Alliqua CEO Dave Johnson 8:19 a.m. June 4, 2014 - Seeking Alpha
NanoString to develop a companion diagnostic test for Celgene 5:03 p.m. June 3, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: CAT, CELG, BIDU 11:29 a.m. June 3, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – LGND VRX CELG LCI 2:00 p.m. June 2, 2014 - InvestorPlace.com
Stock Market News for June 02, 2014 - Market News 10:06 a.m. June 2, 2014 - Zacks.com
Celgene's Management Presents at Sanford C Bernstein Strategic Decisions Conference (Transcript) 8:46 p.m. May 29, 2014 - Seeking Alpha
Array BioPharma Collaborates with Biogen - Analyst Blog 5:10 p.m. May 29, 2014 - Zacks.com
Biogen Upgraded, Celgene Downgraded On Pipelines 2:18 p.m. May 29, 2014 - Investors Business Daily
Analysts' Actions: Biogen Idec, Home Away, Palo Alto, Twitter 8:30 a.m. May 29, 2014 - TheStreet.com
How Will Celgene (CELG) Stock Be Affected By This Analyst Action? 8:17 a.m. May 29, 2014 - TheStreet.com
UPDATE: JP Morgan Downgrades Celgene On Less Upside, Remains Optimistic On Growth 8:10 a.m. May 29, 2014 - benzinga.com
Top Analyst Upgrades and Downgrades: AngloGold, Twitter, Biogen, Celgene, HomeAway, VMware and More 7:17 a.m. May 29, 2014 - 247WallSt.com
Benzinga's Top Downgrades 7:07 a.m. May 29, 2014 - benzinga.com
Gene Technology Regains Some of Its Luster 6:28 p.m. May 28, 2014 - The Wall Street Journal Interactive Edition
Cramer's Mad Money - Father Versus Son (5/27/14) 6:23 a.m. May 28, 2014 - Seeking Alpha
Celgene Shares Respond To Word Of Markman Opinion Release 1:23 p.m. May 27, 2014 - benzinga.com
3 Health Care Stocks Nudging The Sector Higher 1:02 p.m. May 27, 2014 - TheStreet.com
Post-Hoc Analysis of Overall Survival in Phase III MPACT Study of Patients with Advanced Pancreatic Cancer Presented at ASCO 2014 9:01 a.m. June 1, 2014 - BusinessWire - BZX
Veracyte, Foundation Medicine and Panacea Global Paving Way in Faster, More Accurate Cancer Diagnostics 9:53 a.m. May 29, 2014 - ACCESSWIRE
Breakthrough Innovation for Animal Health, Upcoming Conference Presentations, and New Treatment Options for Patients - Analyst Notes on Merck, Actavis, Celgene, Bristol-Myers Squibb and GSK 5:50 a.m. May 29, 2014 - PR Newswire - PRF
Organizational Changes Strengthen and Expand Celgene Leadership Team 6:00 a.m. May 22, 2014 - BusinessWire - BZX
Marketing Authorizations, Study Results Presentations, FDA Response to Drug Application, and New Messaging Services - Analyst Notes on Johnson & Johnson, Merck, Celgene, Novartis and UnitedHealth 8:41 a.m. May 21, 2014 - PR Newswire - PRF
AADi Announces Licensing Agreement with Celgene for Nanotechnology-Based Drug Candidate 9:00 a.m. May 20, 2014 - PR Newswire - PRF
Celgene Corporation to Present at Investor Conferences in June 8:31 a.m. May 20, 2014 - BusinessWire - BZX
Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index 8:05 a.m. May 19, 2014 - GlobeNewswire
Upcoming Conferences, Stock Price Movements and Support to Humanitarian Programs - Analyst Notes on Celgene, Biogen Idec, Incyte, Jazz Pharmaceuticals and Medivation 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2014 5:19 p.m. May 14, 2014 - BusinessWire - BZX
Critical Alerts For DirecTV, JPMorgan, First Solar, Celgene, and Baidu.com Released By InvestorsObserver 9:31 a.m. May 14, 2014 - PR Newswire - PRF
Clinical Trial Results, Acquisitions, Healthcare Partnership, and Pricing of Senior Notes - Analyst Notes on Merck, JNJ, Chelsea, Unitedhealth and Celgene 7:20 a.m. May 13, 2014 - PR Newswire - PRF
Celgene Prices $2.5 Billion of Senior Unsecured Notes 7:32 a.m. May 7, 2014 - BusinessWire - BZX
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
Celgene Announces Offering of Senior Unsecured Notes 8:32 a.m. May 6, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Social Initiatives, and Upcoming Conferences - Analyst Notes on Merck, WellPoint, UnitedHealth, Forest and Celgene 8:00 a.m. May 5, 2014 - PR Newswire - PRF
New Drug Applications, Quarterly Results, and University Partnerships - Analyst Notes on Celgene, HCA, Thermo Fisher Scientific, Cubist and Agilent 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Critical Alerts For Coca Cola, Baidu.com, Urban Outfitters, Celgene, and Trina Solar Released By InvestorsObserver 9:31 a.m. May 1, 2014 - PR Newswire - PRF
Celgene Corporation to Present at Investor Conferences in May 8:30 a.m. April 25, 2014 - BusinessWire - BZX
Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Celgene drops 1.9%, among worst S&P 500 losers 9:32 a.m. May 29, 2014 - Sue Chang
Higher rates are coming — here’s how you prepare 8:38 a.m. May 12, 2014 - Jeff Reeves
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
What ‘Game of Thrones’ can teach you about money 8:30 a.m. April 5, 2014 - Wallace Witkowski
Biotechs, bonds and more from the 'tempest in a microsecond' 8:32 a.m. April 2, 2014 - Shawn Langlois
Play-it-safe stock investors may take some risk on jobs 8:31 a.m. March 30, 2014 - Wallace Witkowski
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - Russ Britt
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - Russ Britt
The Nasdaq has a message to deliver 1:57 p.m. March 20, 2014 - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:16 p.m. March 14, 2014 - Sue Chang
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
Winning approval for new drugs may get harder, analyst warns 4:56 p.m. Feb. 28, 2014 - Russ Britt
The market puts a few feathers in its cap 2:58 p.m. Jan. 23, 2014 - The Trading Deck
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Celgene's 2014 guidance falls below analyst views 1:19 p.m. Jan. 13, 2014 - MarketWatch.com
Jim Cramer's Top Stock Picks: PVH CELG REGN SKX 6:00 a.m. Today - TheStreet.com
Cramer's Mad Money - Skechers Is Totally Nailing It (6/4/14) 4:41 a.m. Today - Seeking Alpha
Celgene's (CELG) Management Hosts Jefferies Global Healthcare Conference (Transcript) 1:27 p.m. June 4, 2014 - Seeking Alpha
A Celgene Satellite: An Interview With Alliqua CEO Dave Johnson 8:19 a.m. June 4, 2014 - Seeking Alpha
NanoString to develop a companion diagnostic test for Celgene 5:03 p.m. June 3, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: CAT, CELG, BIDU 11:29 a.m. June 3, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – LGND VRX CELG LCI 2:00 p.m. June 2, 2014 - InvestorPlace.com
Stock Market News for June 02, 2014 - Market News 10:06 a.m. June 2, 2014 - Zacks.com
Celgene's Management Presents at Sanford C Bernstein Strategic Decisions Conference (Transcript) 8:46 p.m. May 29, 2014 - Seeking Alpha
Array BioPharma Collaborates with Biogen - Analyst Blog 5:10 p.m. May 29, 2014 - Zacks.com
Biogen Upgraded, Celgene Downgraded On Pipelines 2:18 p.m. May 29, 2014 - Investors Business Daily
Analysts' Actions: Biogen Idec, Home Away, Palo Alto, Twitter 8:30 a.m. May 29, 2014 - TheStreet.com
How Will Celgene (CELG) Stock Be Affected By This Analyst Action? 8:17 a.m. May 29, 2014 - TheStreet.com
UPDATE: JP Morgan Downgrades Celgene On Less Upside, Remains Optimistic On Growth 8:10 a.m. May 29, 2014 - benzinga.com
Top Analyst Upgrades and Downgrades: AngloGold, Twitter, Biogen, Celgene, HomeAway, VMware and More 7:17 a.m. May 29, 2014 - 247WallSt.com
Benzinga's Top Downgrades 7:07 a.m. May 29, 2014 - benzinga.com
Gene Technology Regains Some of Its Luster 6:28 p.m. May 28, 2014 - The Wall Street Journal Interactive Edition
Cramer's Mad Money - Father Versus Son (5/27/14) 6:23 a.m. May 28, 2014 - Seeking Alpha
Celgene Shares Respond To Word Of Markman Opinion Release 1:23 p.m. May 27, 2014 - benzinga.com
3 Health Care Stocks Nudging The Sector Higher 1:02 p.m. May 27, 2014 - TheStreet.com
Post-Hoc Analysis of Overall Survival in Phase III MPACT Study of Patients with Advanced Pancreatic Cancer Presented at ASCO 2014 9:01 a.m. June 1, 2014 - BusinessWire - BZX
Veracyte, Foundation Medicine and Panacea Global Paving Way in Faster, More Accurate Cancer Diagnostics 9:53 a.m. May 29, 2014 - ACCESSWIRE
Breakthrough Innovation for Animal Health, Upcoming Conference Presentations, and New Treatment Options for Patients - Analyst Notes on Merck, Actavis, Celgene, Bristol-Myers Squibb and GSK 5:50 a.m. May 29, 2014 - PR Newswire - PRF
Organizational Changes Strengthen and Expand Celgene Leadership Team 6:00 a.m. May 22, 2014 - BusinessWire - BZX
Marketing Authorizations, Study Results Presentations, FDA Response to Drug Application, and New Messaging Services - Analyst Notes on Johnson & Johnson, Merck, Celgene, Novartis and UnitedHealth 8:41 a.m. May 21, 2014 - PR Newswire - PRF
AADi Announces Licensing Agreement with Celgene for Nanotechnology-Based Drug Candidate 9:00 a.m. May 20, 2014 - PR Newswire - PRF
Celgene Corporation to Present at Investor Conferences in June 8:31 a.m. May 20, 2014 - BusinessWire - BZX
Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index 8:05 a.m. May 19, 2014 - GlobeNewswire
Upcoming Conferences, Stock Price Movements and Support to Humanitarian Programs - Analyst Notes on Celgene, Biogen Idec, Incyte, Jazz Pharmaceuticals and Medivation 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2014 5:19 p.m. May 14, 2014 - BusinessWire - BZX
Critical Alerts For DirecTV, JPMorgan, First Solar, Celgene, and Baidu.com Released By InvestorsObserver 9:31 a.m. May 14, 2014 - PR Newswire - PRF
Clinical Trial Results, Acquisitions, Healthcare Partnership, and Pricing of Senior Notes - Analyst Notes on Merck, JNJ, Chelsea, Unitedhealth and Celgene 7:20 a.m. May 13, 2014 - PR Newswire - PRF
Celgene Prices $2.5 Billion of Senior Unsecured Notes 7:32 a.m. May 7, 2014 - BusinessWire - BZX
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
Celgene Announces Offering of Senior Unsecured Notes 8:32 a.m. May 6, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Social Initiatives, and Upcoming Conferences - Analyst Notes on Merck, WellPoint, UnitedHealth, Forest and Celgene 8:00 a.m. May 5, 2014 - PR Newswire - PRF
New Drug Applications, Quarterly Results, and University Partnerships - Analyst Notes on Celgene, HCA, Thermo Fisher Scientific, Cubist and Agilent 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Critical Alerts For Coca Cola, Baidu.com, Urban Outfitters, Celgene, and Trina Solar Released By InvestorsObserver 9:31 a.m. May 1, 2014 - PR Newswire - PRF
Celgene Corporation to Present at Investor Conferences in May 8:30 a.m. April 25, 2014 - BusinessWire - BZX
Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW 8:00 a.m. April 25, 2014 - PR Newswire - PRF
(0)
(0)